The Food and Drug Administration (FDA) said on Monday it has authorized a new over-the-counter COVID-19 rapid antigen test that will “double the rapid home testing capacity in the US over the next several weeks.” hope to do.”
The FDA has emergency use authorization for the ACON Laboratories Flowflex COVID-19 Home Test, which can be used at home without a prescription.
Akon, a San Diego-based company, plans to produce more than 100 million tests per month and 200 per month by February 2022, the FDA said in a statement.
The test involves nasal swabs and yields results within about 15 minutes – much less than PCR (polymerase chain reaction) tests, which take 1-5 days to do.
White House COVID-19 Response Coordinator Jeff Ziants acknowledged on October 1 that rapid testing at home is “under great demand,” but that construction will increase and double over the next several months.
“We’re going to continue to do this to encourage those manufacturers to increase capacity and reduce the cost of those tests,” he said. “Therefore, we will continue to do everything possible to rapidly expand at-home testing facilities.”
It comes as the Defense Department announced the same day that its logistics agency had signed six contracts with a combined value of more than $2.78 billion for at-home and $400 million point-of-care test COVID-19 testing kits. lamps. The move is in support of the Biden administration’s efforts to tackle COVID-19.
This News Originally From – The Epoch Times